Ocular Therapeutix

News

Sanofi is reported to be preparing a move to take control of US biotech Ocular Therapeutix, after an initial bid was rejected last year.

News

In a busy week, the FDA granted two De Novo authorisations for consumer health devices and is rumoured to be mulling structural leadership changes.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.